PE Buyer vs Strategic Buyer — Who Pays More and Why
Strategics pay 15-30% above PE in the same vertical. PE pays for platforms; strategics pay for synergy.
The bottom line
Strategics will outbid PE when there are real synergies (cost overlap, revenue cross-sell, geographic complement). PE wins when no strategic has a strong synergy case OR when the deal is too big for any strategic to underwrite alone. The exception: in PE-platform building mode, the consolidator IS effectively a strategic for their roll-up vertical — they'll pay strategic multiples for the right add-on.
Side-by-side comparison
| Aspect | Private Equity (PE) Buyer | Strategic Buyer (operating company) |
|---|---|---|
| Typical multiple paid | 5-8x EBITDA for SMB platforms; 8-12x for established platforms; 12-18x for premium verticals | 15-30% premium to PE comparable due to synergy underwriting; sometimes 2x+ if revenue synergy is real |
| How they underwrite | DCF + LBO model; needs to support debt service + equity return; very sensitive to growth assumption | Synergy case + accretion math; can pay higher because operational savings offset goodwill |
| Process speed | Slower — IC committee, debt-fund, lender review. 5-8 months typical. | Faster — single decision-maker (CEO/Board). 3-5 months possible if motivated. |
| Diligence intensity | Heavy QofE, customer calls, IT/data room scrutiny. 6-10 weeks. | Often lighter on financial diligence (they understand the business); heavier on commercial/customer diligence |
| Post-close | Owner usually rolls equity (10-30%) and stays as CEO 2-5 years; PE installs CFO + reporting | Owner often paid out and exits in 12-18 months; integration into buyer's org |
| Best for sellers who want | Second bite of the apple via rollover equity; remain operationally involved | Clean exit; faster process; one fewer counterparty in the financing stack |
| Red flags by buyer type | PE platform from a fund whose vintage is ending — they're motivated but may discount; lots of late-stage debt | Strategic without a clear synergy story is overpaying; that's a warning sign they'll trim it back in earnout |
Get a real number for your business
Three-field instant valuation range. Backed by 25,592 real M&A transactions. No signup.
Run a valuation →Other comparisons
Based on standard M&A practice and 4 years of healthcare-services M&A advisory experience. Edge cases vary by deal — not legal or tax advice. Methodology